Guys, I am new to this stock and I really enjoy its great ride. However, PRs published 2 years ago saying very similar things as the last one really puzzle me: www.xechem.com Sept 02, 2003: Xechem's Sickle Cell Drug, NIPRISAN -HEMOXIN- Granted Orphan Drug Status by the FDA Feb 03, 2003: XECHEM ANNOUNCES LAUNCH OF NICOSAN™ (formerly “Niprisan”)
Could you explain it? Given you did an extensive research on this company I hope you know the answer. I just do not want to have unrealistic hopes
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.